The abstract is read at the publisher; the summary is JClub's.
Simulation-guided trial design can optimize complex clinical trial strategies by evaluating operating characteristics, including type I error, false discovery rate, power, and interim adaptive decision probabilities.
- Why it matters: Innovative trial designs may speed discovery and improve outcomes, but their added complexity can hinder conduct and interpretation without a way to test performance beforehand.
- What they did: The authors describe using trial simulations to assess operating characteristics and to inspect individual simulated trials, supporting sample size determination and refinement of adaptive interim decisions.
- The result: They argue simulation improves cross-functional communication and provides objective justification, alongside best-practice guidance to make simulations valid, transparent, thorough, efficient, and comparable.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.